Augmentation of vestibular evoked myogenic potentials: an indication for distended saccular hydrops
- PMID: 12148863
- DOI: 10.1097/00005537-200203000-00019
Augmentation of vestibular evoked myogenic potentials: an indication for distended saccular hydrops
Abstract
Objective/hypothesis: Vestibular evoked myogenic potential (VEMP) testing has become a well-established test to explore the sacculo-collic pathways in human. The aim of the present study is to establish a clinical indication for saccular hydrops by VEMP testing.
Study design: Prospective study.
Methods: Ten patients (three men and seven women) with Meniere's disease and 10 patients (four men and six women) with sudden deafness were admitted and given pure-tone audiometry and VEMP testing daily. Interaural amplitude difference over the sum of amplitudes of both ears was measured, and when the ratio exceeded 0.36, the test result was coined "augmented VEMP."
Results: During admission, three hydropic ears presented with augmented VEMP test results, with increased interaural amplitude difference ratio (mean difference ratio, 0.40+/-0.03). Seven hydropic ears had steady VEMP test results, with a mean interaural amplitude difference ratio of 0.15+/-0.07. Compared with the normal control ears, all had steady VEMP test results, with a mean interaural amplitude difference ratio of 0.14+/-0.11, which is significantly different from the hydropic ears with augmented VEMP test results (P <.05). In another 10 patients with sudden deafness, all had positive steady VEMP test results, with their mean interaural amplitude difference ratio of 0.14+/-0.12, which is similar to that in the control ears.
Conclusions: Augmented VEMP test results are an indication of distended saccular hydrops, whose distended wall is in contact with the footplate. VEMP testing may be beneficial in differentiating the initial stage of Meniere's disease and sudden deafness.
Similar articles
-
Vestibular evoked myogenic potentials in delayed endolymphatic hydrops.Laryngoscope. 2002 Sep;112(9):1623-6. doi: 10.1097/00005537-200209000-00018. Laryngoscope. 2002. PMID: 12352676
-
Vestibular-evoked myogenic potential in the prediction of recovery from acute low-tone sensorineural hearing loss.Ear Hear. 2010 Apr;31(2):289-95. doi: 10.1097/AUD.0b013e3181c5b743. Ear Hear. 2010. PMID: 20054280 Clinical Trial.
-
Visualization of endolymphatic hydrops and correlation with audio-vestibular functional testing in patients with definite Meniere's disease.Auris Nasus Larynx. 2013 Apr;40(2):167-72. doi: 10.1016/j.anl.2012.07.009. Epub 2012 Aug 4. Auris Nasus Larynx. 2013. PMID: 22867525
-
Clinical application of vestibular evoked myogenic potential (VEMP).Auris Nasus Larynx. 2016 Aug;43(4):367-76. doi: 10.1016/j.anl.2015.12.006. Epub 2016 Jan 11. Auris Nasus Larynx. 2016. PMID: 26791591 Review.
-
Vestibular evoked myogenic potentials.Curr Opin Otolaryngol Head Neck Surg. 2006 Oct;14(5):299-304. doi: 10.1097/01.moo.0000244185.65022.01. Curr Opin Otolaryngol Head Neck Surg. 2006. PMID: 16974141 Review.
Cited by
-
Diagnostic Value of Vestibular Evoked Myogenic Potentials in Endolymphatic Hydrops: A Meta-Analysis.Sci Rep. 2015 Oct 12;5:14951. doi: 10.1038/srep14951. Sci Rep. 2015. PMID: 26455332 Free PMC article.
-
Vestibular Function After Cochlear Implantation in Partial Deafness Treatment.Front Neurol. 2021 May 21;12:667055. doi: 10.3389/fneur.2021.667055. eCollection 2021. Front Neurol. 2021. PMID: 34093414 Free PMC article.
-
Saccular damage in patients with high-frequency sensorineural hearing loss.Eur Arch Otorhinolaryngol. 2006 Jul;263(7):608-13. doi: 10.1007/s00405-006-0038-6. Epub 2006 Apr 20. Eur Arch Otorhinolaryngol. 2006. PMID: 16625399
-
Vestibular evoked myogenic potentials in affected and asymptomatic ears in unilateral Ménière's disease.Braz J Otorhinolaryngol. 2005 Jan-Feb;71(1):60-6. doi: 10.1016/s1808-8694(15)31286-6. Epub 2006 Jan 2. Braz J Otorhinolaryngol. 2005. PMID: 16446893 Free PMC article.
-
Significance of an augmented response on cervical vestibular evoked myogenic potential testing in Meniere's disease.Nagoya J Med Sci. 2023 May;85(2):375-379. doi: 10.18999/nagjms.85.2.375. Nagoya J Med Sci. 2023. PMID: 37346840 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical